4.10
price down icon0.24%   -0.01
pre-market  Pre-mercato:  4.10  
loading
Precedente Chiudi:
$4.11
Aprire:
$4.11
Volume 24 ore:
920.36K
Relative Volume:
0.36
Capitalizzazione di mercato:
$351.56M
Reddito:
$103.00K
Utile/perdita netta:
$-42.47M
Rapporto P/E:
-2.1579
EPS:
-1.9
Flusso di cassa netto:
$-34.30M
1 W Prestazione:
+1.49%
1M Prestazione:
+1.49%
6M Prestazione:
+6.77%
1 anno Prestazione:
+185.71%
Intervallo 1D:
Value
$4.09
$4.115
Intervallo di 1 settimana:
Value
$4.04
$4.13
Portata 52W:
Value
$1.38
$4.50

Checkpoint Therapeutics Inc Stock (CKPT) Company Profile

Name
Nome
Checkpoint Therapeutics Inc
Name
Telefono
781-652-4500
Name
Indirizzo
95 SAWYER ROAD, WALTHAM, NY
Name
Dipendente
24
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
CKPT's Discussions on Twitter

Confronta CKPT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CKPT
Checkpoint Therapeutics Inc
4.10 351.56M 103.00K -42.47M -34.30M -1.90
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
503.50 126.09B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
568.91 64.01B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
629.51 36.63B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
257.19 30.64B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
249.77 27.24B 3.81B -644.79M -669.77M -6.24

Checkpoint Therapeutics Inc Stock (CKPT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-01-13 Iniziato D. Boral Capital Buy
2022-07-14 Ripresa B. Riley Securities Buy
2021-06-09 Iniziato B. Riley Securities Buy
2021-01-20 Iniziato Cantor Fitzgerald Overweight
2019-05-29 Iniziato Lake Street Buy
2017-12-08 Iniziato H.C. Wainwright Buy
Mostra tutto

Checkpoint Therapeutics Inc Borsa (CKPT) Ultime notizie

pulisher
Apr 29, 2025

CHECKPOINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkpoint Therapeutics, Inc.CKPT - marketscreener.com

Apr 29, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 21, 2025

Sun Pharma shares in focus as co to acquire Checkpoint Therapeutics for $355 million - MSN

Apr 21, 2025
pulisher
Apr 19, 2025

2025-04-19 | SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CKPT, QTRX, AKYA on Behalf of Shareholders | NDAQ:CKPT | Press Release - Stockhouse

Apr 19, 2025
pulisher
Apr 18, 2025

$TOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The MergerBRDG, AKYA, CKPT, QTRX - Longview News-Journal

Apr 18, 2025
pulisher
Apr 04, 2025

Checkpoint therapeutics CFO Garrett Gray sells $49,904 in stock By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

High Growth Tech Stocks in the US for April 2025 - simplywall.st

Apr 04, 2025
pulisher
Apr 04, 2025

3 Growth Companies Insiders Are Betting On - Yahoo Finance

Apr 04, 2025
pulisher
Apr 03, 2025

Checkpoint Therapeutics CEO sells stock for $60,963 By Investing.com - Investing.com Canada

Apr 03, 2025
pulisher
Apr 03, 2025

Checkpoint therapeutics CFO Garrett Gray sells $49,904 in stock - Investing.com India

Apr 03, 2025
pulisher
Apr 03, 2025

Checkpoint Therapeutics Executives Sell Shares for Tax Obligations - TradingView

Apr 03, 2025
pulisher
Mar 31, 2025

Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights - The Manila Times

Mar 31, 2025
pulisher
Mar 31, 2025

Fortress Biotech Transforms Portfolio: Dual FDA Wins, $28M Deal, Latest Earnings - Stock Titan

Mar 31, 2025
pulisher
Mar 29, 2025

Checkpoint Therapeutics Full Year 2024 Earnings: US$1.42 loss per share (vs US$1.87 loss in FY 2023) - Yahoo Finance

Mar 29, 2025
pulisher
Mar 28, 2025

Checkpoint Therapeutics Reports 2024 Financial Results and Merger - TipRanks

Mar 28, 2025
pulisher
Mar 28, 2025

Checkpoint Therapeutics Inc. (CKPT) reports earnings - Quartz

Mar 28, 2025
pulisher
Mar 28, 2025

Checkpoint Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Checkpoint Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates - The Manila Times

Mar 28, 2025
pulisher
Mar 28, 2025

Breakthrough: CKPT Secures FDA Approval and $416M Merger Deal in Transformative Year - Stock Titan

Mar 28, 2025
pulisher
Mar 21, 2025

GLAZER CAPITAL, LLC Acquires Significant Stake in Checkpoint Therapeutics Inc - GuruFocus

Mar 21, 2025
pulisher
Mar 21, 2025

Beryl Capital Management LLC's Strategic Acquisition of Checkpoi - GuruFocus.com

Mar 21, 2025
pulisher
Mar 21, 2025

GLAZER CAPITAL, LLC Acquires Significant Stake in Checkpoint The - GuruFocus

Mar 21, 2025
pulisher
Mar 17, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CMRX, WBA, CKPT on Behalf of Shareholders - Morningstar

Mar 17, 2025
pulisher
Mar 16, 2025

Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) Shift From Loss To Profit - Yahoo

Mar 16, 2025
pulisher
Mar 13, 2025

Sun Pharma To Acquire Nasdaq-Listed Checkpoint Therapeutics For $355 Million - MSN

Mar 13, 2025
pulisher
Mar 13, 2025

SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of ... - Bluefield Daily Telegraph

Mar 13, 2025
pulisher
Mar 13, 2025

SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options - GlobeNewswire Inc.

Mar 13, 2025
pulisher
Mar 13, 2025

10,081 Shares in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Bought by SBI Securities Co. Ltd. - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

Sun Pharma is betting big on speciality. Will it pay off? | Stock Market News - Mint

Mar 13, 2025
pulisher
Mar 12, 2025

How Acquiring Checkpoint Therapeutics Inc Adds Value to Sun Pharma? - Smartkarma

Mar 12, 2025
pulisher
Mar 12, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Mar 12, 2025
pulisher
Mar 12, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (NasdaqCKPT), Redfin Corporation (NasdaqRDFN), Amplify Energy Corp. (NYSEAMPY), Blackboxstocks Inc. (NasdaqBL - Morningstar

Mar 12, 2025
pulisher
Mar 12, 2025

Sun Pharma to Acquire Checkpoint Therapeutics in Oncology Expansion - Chemical Industry Digest

Mar 12, 2025
pulisher
Mar 12, 2025

Checkpoint Therapeutics’ (CKPT) “Neutral” Rating Reaffirmed at HC Wainwright - Defense World

Mar 12, 2025
pulisher
Mar 12, 2025

Checkpoint Therapeutics Target of Unusually Large Options Trading (NASDAQ:CKPT) - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

This Lennar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga

Mar 11, 2025
pulisher
Mar 11, 2025

Major Acquisition Deal in Pharmaceutical Industry: Sun Pharma to Acquire Checkpoint Therapeutics - Dalal Street Investment Journal

Mar 11, 2025
pulisher
Mar 11, 2025

Sun Pharma to acquire Checkpoint Therapeutics Inc for up to USD 355 mn - Press Trust of India

Mar 11, 2025
pulisher
Mar 11, 2025

Sun Pharma shares rise over 2 pc as company to acquire Checkpoint Therapeutics - Press Trust of India

Mar 11, 2025
pulisher
Mar 11, 2025

3 Penny Stocks to Watch Now, 11/3/25 - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Checkpoint Therapeutics (NASDAQ:CKPT) Receives Hold Rating from Lake Street Capital - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

Sun Pharma surges 3%. 3 reasons why Motilal Oswal has ‘Buy’ rating - The Financial Express

Mar 11, 2025
pulisher
Mar 11, 2025

Sun Pharma to acquire oncology therapy company Checkpoint in US - domain-b.com: The first online Indian business magazine

Mar 11, 2025
pulisher
Mar 11, 2025

Checkpoint Therapeutics (NASDAQ:CKPT) Given Buy Rating at D. Boral Capital - Defense World

Mar 11, 2025
pulisher
Mar 11, 2025

Sun Pharma to acquire a US-based oncology firm in a deal exceeding ₹3,000 crore - Bizz Buzz

Mar 11, 2025
pulisher
Mar 11, 2025

Despite near-term challenges, brokerages remain positive on Sun Pharma - Business Standard

Mar 11, 2025
pulisher
Mar 10, 2025

Sun Pharma to acquire US oncology compony for over Rs 3,000 crore - MSN

Mar 10, 2025
pulisher
Mar 10, 2025

CKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale to Sun Pharma - Longview News-Journal

Mar 10, 2025
pulisher
Mar 10, 2025

Checkpoint Therapeutics gets picked up by Sun Pharma, enjoys 60% share bump - Mugglehead Magazine

Mar 10, 2025

Checkpoint Therapeutics Inc Azioni (CKPT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.79
price up icon 0.78%
$71.40
price up icon 2.20%
$32.71
price up icon 0.52%
$23.62
price down icon 2.03%
$104.00
price up icon 0.00%
biotechnology ONC
$249.77
price up icon 0.12%
Capitalizzazione:     |  Volume (24 ore):